A number of black SA individuals, strongly suspected of having FA based on their clinical features, have now been found to be
heterozygous for the c.637-643delTACCGCC founder mutation.
There were no statistically significant association with homozygous and compound
heterozygous mutation carriage and presence of FMF symptoms in our study population (Figure 2).
In a previous study, a 22 year old male diagnosed with delayed puberty at 18 years was found to have compound
heterozygous GNRHR mutations Gln106Arg and Arg262Gln.
Hb concentration in sickle cell
heterozygous (AS) group ranged from 2.6-14.86 g/dL.
In our study, a homozygous mutation c.1139_1141dupGCG(p.Gly380_Ala381insGly) and a
heterozygous mutation c.1359_1361dupCGG(p.Gly456_Gln457insGly) in FOXC1 were found in all subjects, but their clinical findings were variable.
Individuals with autosomal recessive PCD carry biallelic PROC mutations and have very low level of protein C, whereas individuals carrying
heterozygous PROC mutations have protein C level at about 50% of reference values [1].
[11] showed that 54% of CNS cases had two
heterozygous mutations and 2.5% had a compound of a
heterozygous mutation and a nonsilent variant in the nephrin gene.
Men, "Basilar artery thrombosis in a child
heterozygous for prothrombin gene G20210A mutation," in Journal of Child Neurology, vol.
Overall, the model showed that adding PCSK9 to statins for patients with
heterozygous FH or ASCVD prevented 316,300 major adverse cardiovascular events (defined as cardiovascular death, nonfatal MI, or stroke), compared with adding ezetimibe; the cost was $503,000 per QALY.
The report provides comprehensive information on the therapeutics under development for
Heterozygous familial hypercholesterolemia (heFH), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Out of 16 sub-types of Haemoglobin D, Hb-D Punjab or Los-Angeles is most common with 0.86% in Indo-Pakistan continent and 3.6% alone in Punjab.1 Hb-D can be homozygous, usually a rare entity with no clinical symptoms or can be
heterozygous commonly with Haemoglobin-A, a benign alteration.